Repaglinide 1mg tablets
BNF presentation 0601023R0AAABAB within chapter Endocrine System. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Chapter
Presentation code
0601023R0AAABAB
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
4,371
NHS spend (£)
£26,117.66
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 487 |
| February 2025 | 3 |
| December 2024 | 160 |
| November 2024 | 570 |
| October 2024 | 599 |
| September 2024 | 3 |
| August 2024 | 44 |
| July 2024 | 607 |
| May 2024 | 139 |
| July 2021 | 223 |
| June 2021 | 152 |
| December 2020 | 666 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 58 | No data available |
| Unknown pharmacy | 45 | No data available |
| Unknown pharmacy | 36 | No data available |
| Unknown pharmacy | 33 | No data available |
| Unknown pharmacy | 32 | No data available |
| Unknown pharmacy | 32 | No data available |
| Unknown pharmacy | 26 | No data available |
| Unknown pharmacy | 25 | No data available |
| Unknown pharmacy | 25 | No data available |
| Unknown pharmacy | 24 | No data available |